Loading...
OTCM
ONTTF
Market cap1.56bUSD
Jul 09, Last price  
1.61USD
1D
0.53%
1Q
10.03%
IPO
-81.25%
Name

Oxford Nanopore Technologies PLC

Chart & Performance

D1W1MN
OTCM:ONTTF chart
P/E
P/S
5.22
EPS
Div Yield, %
Shrs. gr., 5y
3.87%
Rev. gr., 5y
14.48%
Revenues
224m
+22.22%
149,49100746,0004,529,00013,787,00032,521,00052,061,000113,860,000133,661,000198,603,000169,668,000183,191,000223,900,000
Net income
-145m
L-0.68%
-19,159,495-24,215,000-36,973,000-38,511,000-59,101,000-56,536,000-53,119,000-72,216,000-61,244,000-167,613,000-91,025,000-154,507,000-146,188,000-145,200,000
CFO
-63m
L-42.85%
-21,274,143-23,270,000-33,876,000-33,138,000-51,207,000-66,345,000-55,509,000-48,679,000-63,806,000-53,826,000-49,387,000-137,302,000-109,885,000-62,800,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Oxford Nanopore Technologies plc, founded in 2005 and originally known as Oxford NanoLabs Limited before its name change in May 2008, is a United Kingdom-based enterprise that specializes in developing and commercializing an innovative system for analyzing diverse molecular structures through nanopore-based sensing. Its product range features a variety of devices, including the portable MinION for sequencing deoxyribonucleic acid and ribonucleic acid, and the MinION Mk1C, which integrates basecalling, data analysis, touchscreen controls, and wireless connectivity. For benchtop operations, the company offers the GridION, capable of running and analyzing up to five MinION or Flongle flow cells, as well as the GridION Mk1 nanopore sequencer. High-yield sequencing is made accessible with the PromethION 2 Solo and PromethION 2, while the PromethION 24 and PromethION 48 provide benchtop nanopore sequencers for multiple users to achieve multi-sample and multi-experiment results. Further complementing these devices are Flongle, an adapter for MinION or GridION units, and VolTRAX, a USB-powered tool designed to automate laboratory processes preceding nanopore sequencing. The company also provides a suite of software solutions: MinKNOW facilitates data acquisition, real-time analysis and feedback, local basecalling, and data streaming; specialized Basecalling tools pinpoint the identity and sequence of bases on DNA/RNA molecules; EPI2ME is a cloud-based platform for comprehensive, real-time analysis of nanopore data; and EPI2ME Labs offers bioinformatics support to help users refine their skills and confidence in analyzing their sequencing data. Additionally, Oxford Nanopore Technologies is actively developing new products such as MinION Mk1D, Ubi, Plongle, and SmidgION. All of its products are available for purchase online.
IPO date
Sep 30, 2021
Employees
1,049
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT